Vaccibody reports positive results from clinical Phase I study
(06.09.16)

| News

Vaccibody announces positive results from the Phase I part of the clinical trial VB C-01 in patients with high-grade cervical dysplasia and recommendation by the Cohort Review Committee as well as the independent data monitoring board to continue to the expansion Phase IIa. Read more

Sarsia Seed